Data as of Jul 31
| 0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 9.20, with a high estimate of 26.00 and a low estimate of 8.38. The median estimate represents a +152.05% increase from the last price of 3.65.
The current consensus among 5 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.